627871-16-3

Basic information

• Product Name: 5-BROMO-4-FLUORO-2-METHYLANILINE
• Synonyms: 2-Amino-4-bromo-5-fluorotoluene, 5-Bromo-4-fluoro-o-toluidine;BenzenaMine,5-broMo-4-fluoro-2-Methyl-;2-AMino-4-broMo-5-fluorotoluene[5-BroMo-4-fluoro-2-Methylaniline]
• CAS NO: 627871-16-3
• Molecular Formula: C₇H₇BrFN
• Molecular Weight: 204.05
• Product Categories: Amines;C7;Nitrogen Compounds;Aryl Fluorinated Building Blocks;Building Blocks;C7-C8;Chemical Synthesis;Fluorinated Building Blocks;Nitrogen Compounds;Organic Building Blocks;Organic Fluorinated Building Blocks;Other Fluorinated Organic Building Blocks
• Mol File: 627871-16-3.mol

Chemical Properties

• Melting Point: 86-90 °C(lit.)
• Boiling Point: 266.3°C at 760 mmHg
• Flash Point: 114.9°C
• Appearance: /Solid
• Density: 1.589g/cm³
• Vapor Pressure: 0.00869mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.44±0.10(Predicted)
• CAS DataBase Reference: 5-BROMO-4-FLUORO-2-METHYLANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-4-FLUORO-2-METHYLANILINE(627871-16-3)
• EPA Substance Registry System: 5-BROMO-4-FLUORO-2-METHYLANILINE(627871-16-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 627871-16-3(Hazardous Substances Data)

Usage

Chemical Properties

light brown solid

InChI:InChI=1/C7H7BrFN/c1-4-2-6(9)5(8)3-7(4)10/h2-3H,10H2,1H3

Upstream product

• 452-74-4 4-bromo-3-fluorotoluene 
• 224185-19-7 3-bromo-4-fluoro-6-methylnitrobenzene 

Downstream Products

• 1126369-79-6 N-(5-bromo-4-fluoro-2-methylphenyl)-4-(pyridin-2-ylmethoxy)benzamide 
• 873922-26-0 5-bromo-4-fluoro-2-methylbenzenethiol 
• 870704-15-7 1-bromo-2-fluoro-5-iodo-4-methylbenzene 
• 2275619-53-7 2-(N-(5-bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-((3,5-dichlorophenyl)sulfonamido)benzoic acid methyl ester 
• 1237518-31-8 N-(5-bromo-4-fluoro-2-methylphenyl)acetamide 

Relevant articles and documents

HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.

Pinacol as a new green reducing agent: Molybdenum-catalyzed chemoselective reduction of sulfoxides and nitroaromatics

Pinacol is disclosed as a new chemoselective and environmentally benign reducing agent for sulfoxides and nitroaromatics assisted by readily available dichlorodioxomolybdenum(VI) complexes as catalysts. A wide range of substrates including those bearing challenging functional groups has been efficiently and selectively reduced with acetone and water being the only by-products of these reactions. Copyright

Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase

A novel class of HCV NS5B RNA dependent RNA polymerase inhibitors containing 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H- pyrano[3,4-b]benzofuran scaffolds were designed and synthesized. Optimization of the alkyl substituent in the pyran ring showed preference for an n-propyl group, while 5,8-disubstitution pattern is preferred for the aromatic region. Analog 19 displayed potent activity with an IC50 of 50 nM against HCV NS5B enzyme and was selective over a panel of polymerases.

Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors

A novel series of HCV NS5B RNA-dependent RNA polymerase inhibitors containing a pyrano-[3,4-b]indole scaffold is described leading to the discovery of compound 16, a highly potent and selective inhibitor that is active in the replicon system.

R-ENANTIOMERS OF PYRANOINDOLE DERIVATIVES AGAINST HEPATITIS C

The invention is directed to a compound and a pharmaceutical composition of the formula: Wherein substitutions at R1, R2, R3 - R12, and Y are set forth in the specification.

METHOD FOR THE USE OF PYRANOINDOLE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS

The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising containing the mammal with an effective amount of a compound of the formula: Wherein substitutions at R1, R2, R3-R12, and Y are set forth in the specification.